Dosimetric factors predicting radiation pneumonitis after CyberKnife stereotactic body radiotherapy for peripheral lung cancer

about

Additional chemotherapy improved local control and overall survival after stereotactic body radiation therapy for patients with oligo-recurrence.

P2860

Q54966222-943B3359-BD2F-4867-93EF-9987644BFD9F

P2860

Dosimetric factors predicting radiation pneumonitis after CyberKnife stereotactic body radiotherapy for peripheral lung cancer

Item

http://www.wikidata.org/entity/Q40496623

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Dosimetric factors predicting ...... apy for peripheral lung cancer

@en

type

Item

label

Dosimetric factors predicting ...... apy for peripheral lung cancer

@en

prefLabel

Dosimetric factors predicting ...... apy for peripheral lung cancer

@en

P1476

Dosimetric factors predicting ...... apy for peripheral lung cancer

@en

P2093

Aya Harada

http://www.w3.org/2001/XMLSchema#string

Haruka Uezono

http://www.w3.org/2001/XMLSchema#string

Hideki Nishimura

http://www.w3.org/2001/XMLSchema#string

Hiroshi Mayahara

http://www.w3.org/2001/XMLSchema#string

Masao Nakayama

http://www.w3.org/2001/XMLSchema#string

Naoki Hashimoto

http://www.w3.org/2001/XMLSchema#string

Ryohei Sasaki

http://www.w3.org/2001/XMLSchema#string

Takeaki Ishihara

http://www.w3.org/2001/XMLSchema#string

P2860

Chest CT for suspected pulmonary complications of oncologic therapies: how I review and report

Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials.

Stereotactic radiotherapy with real-time tumor tracking for non-small cell lung cancer: clinical outcome.

Stereotactic body radiation therapy for inoperable early stage lung cancer.

Clinical outcomes of CyberKnife stereotactic body radiotherapy for peripheral stage I non-small cell lung cancer.

Image-guided robotic stereotactic radiation therapy with fiducial-free tumor tracking for lung cancer.

Clinical outcome and predictors of survival and pneumonitis after stereotactic ablative radiotherapy for stage I non-small cell lung cancer.

Comparison of clinical, tumour-related and dosimetric factors in grade 0-1, grade 2 and grade 3 radiation pneumonitis after stereotactic body radiotherapy for lung tumours.

Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study.

Feasibility of insertion/implantation of 2.0-mm-diameter gold internal fiducial markers for precise setup and real-time tumor tracking in radiotherapy.

P304

20160560

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1259/BJR.20160560

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

1068

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Yasuo Ejima

Masaki Nakamura

P577

2016-11-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27805837

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy

P932

5604921

http://www.w3.org/2001/XMLSchema#string

Dosimetric factors predicting radiation pneumonitis after CyberKnife stereotactic body radiotherapy for peripheral lung cancer

about

P2860

P2860

Dosimetric factors predicting radiation pneumonitis after CyberKnife stereotactic body radiotherapy for peripheral lung cancer

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932